ROMOSOZUMAB vs ROSIGLITAZONE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ROMOSOZUMAB vs ROSIGLITAZONE: Safety Overview
| Metric | ROMOSOZUMAB | ROSIGLITAZONE |
|---|---|---|
| Total FAERS Reports | 434 | 45,976 |
| Deaths Reported | 48 | 4,661 |
| Death Rate | 11.1% | 10.1% |
| Hospitalizations | 81 | 23,675 |
| Average Patient Age | 69.1 yrs | 60.2 yrs |
| % Female Patients | 94.5% | 42.8% |
| FDA Approval Date | N/A | Jan 25, 2013 |
| Manufacturer | Amgen, Inc | N/A |
| Route | SUBCUTANEOUS | N/A |
| Marketing Status | N/A | Discontinued |